Skip to main content
. 2020 Dec 23;10(1):16. doi: 10.3390/jcm10010016

Figure 5.

Figure 5

The management of GO (Graves’ Orbitopathy) depending on the disease severity and activity according to EUGOGO (The European Group on Graves’ Orbitopathy) guidelines [53]. MRI: magnetic resonance imaging, GCS: Glucocorticoids.